Structural analysis of inhibitor binding to human carbonic anhydrase II
暂无分享,去创建一个
Samantha G. Zeitlin | D. Christianson | P. Boriack-Sjodin | S. Zeitlin | Huang‐Hsing Chen | Lori Crenshaw | S. Gross | A. Dantanarayana | Pete Delgado | J. May | T. Dean | Lori Crenshaw | P. Ann Boriack‐Sjodin | Samantha Zeitlin | David W. Christianson | Huang‐Hsing Chen | Sharon Gross | Anura Dantanarayana | Pete Delgado | Jesse A. May | Tom Dean | Huan Chen
[1] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[2] G. Whitesides,et al. Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants. , 1995, Journal of medicinal chemistry.
[3] T. Maren,et al. Carbonic anhydrase: General perspective and advances in glaucoma research , 1987 .
[4] J J Baldwin,et al. Application of the three-dimensional structures of protein target molecules in structure-based drug design. , 1994, Journal of medicinal chemistry.
[5] J. Friedenwald. The formation of the intraocular fluid. , 1949, American journal of ophthalmology.
[6] A. Liljas,et al. Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. , 1992, Journal of molecular biology.
[7] J J Baldwin,et al. Carbonic anhydrase inhibitors for the treatment of glaucoma , 2023, Медицинская этика.
[8] J J Baldwin,et al. Positions of His‐64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors , 1994, Protein science : a publication of the Protein Society.
[9] Carol A. Fierke,et al. Carbonic Anhydrase: Evolution of the Zinc Binding Site by Nature and by Design , 1996 .
[10] A. Liljas,et al. Refined structure of the acetazolamide complex of human carbonic anhydrase II at 1.9 A. , 1990, International Journal of Biological Macromolecules.
[11] R. F. Chen,et al. Combination of bovine carbonic anhydrase with a fluorescent sulfonamide. , 1967, The Journal of biological chemistry.
[12] Mapping Protein-Peptide Affinity: Binding of Peptidylsulfonamide Inhibitors to Human Carbonic Anhydrase II , 1994 .
[13] D. Silverman,et al. The catalytic mechanism of carbonic anhydrase: implications of a rate-limiting protolysis of water , 1988 .
[14] G. Petsko,et al. Weakly polar interactions in proteins. , 1988, Advances in protein chemistry.
[15] M. Karplus,et al. Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.
[16] V. Kinsey. Comparative chemistry of aqueous humor in posterior and anterior chambers of rabbit eye, its physiologic significance. , 1953, A.M.A. archives of ophthalmology.
[17] A. Liljas,et al. The structure of a complex between carbonic anhydrase II and a new inhibitor, trifluoromethane sulphonamide , 1994, FEBS letters.
[18] S. Nair,et al. Unexpected Ph-Dependent Conformation of His-64, the Proton Shuttle of Carbonic Anhydrase II. , 1992 .
[19] D. Keilin,et al. Sulphanilamide as a Specific Inhibitor of Carbonic Anhydrase , 1940, Nature.
[20] G. Whitesides,et al. Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solution-phase and solid-state studies and their use in the development of tight-binding inhibitors. , 1994, Journal of medicinal chemistry.
[21] D. Silverman,et al. Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: Molecular basis of isozyme‐drug discrimination , 1998, Protein science : a publication of the Protein Society.
[22] M. Murcko,et al. New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides. , 1991, Journal of medicinal chemistry.
[23] D. Silverman,et al. Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant. , 1989, Biochemistry.
[24] B. Becker. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. , 1954, American journal of ophthalmology.